ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Correction of the List of reimbursed medicinal products valid as of 8.4.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).  

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes Covered by the Public Health Insurance Scheme (“List”). The List, published on the 1stday of the calendar month, includes a full list of medicinal products (MPs) and foods for special medicinal purposes (FSMPs) covered by the public health insurance scheme that are reimbursed by decision of the Institute, including the maximum or announced ex-factory prices, the amount and terms of reimbursement, incl. the maximum possible reimbursement for the end consumer, and the supplementary payment in the eligible limit.

In addition, the List contains basic reimbursements of reference groups, explaining how the basic reimbursements were set, along with a full list of medicinal products and foods for special medical purposes classified in the reference groups, and the maximum prices of medicinal products and foods for special medical purposes where the Institute has the power to make decisions on the maximum price, and a full list of medicinal products and foods for special medical purposes with an explanation how the maximum prices were set.

List includes 10% and 15% VAT, Price directive of Ministry of Health 1/2020/CAU of 10.12.2019 on the regulation of prices of medicinal products and foods for special medical purposes valid since 1.1.2020 and Price decision 1/19-FAR of 12.12.2018 on the regulation of prices of medicinal products and foods for special medical purposes valid since 1.1.2019.

In this published amendment to the List of Reimbursed Medicinal Products (List), the Institute corrected the identified error regarding the medicinal product KALYDECO, 150MG TBL FLM 56, SUKL code 0185304 which should have not been included in the List. The 2nd temporary reimbursement of 12 months was set in the administrative procedure No. SUKLS255679/2019 which came into force on 25 February 2020 and the decision was effective on 1 April 2020. Hence, the medicinal product should have been removed from the List as of 1 April 2021.

List of prices of medicinal products and foods for special medical purposes                                  

List of prices of medicinal products and foods for special medical purposes used in institutional care only